Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial.

Journal of cardiac failure - 1 Apr 2009

McNamara Dennis M, Tam S William, Sabolinski Michael L, Tobelmann Page, Janosko Karen, Venkitachalam Lakshmi, Ofili Elizabeth, Yancy Clyde, Feldman Arthur M, Ghali Jalal K, Taylor Anne L, Cohn Jay N, Worcel Manuel

Abstract excerpt

BACKGROUND: Genetic heterogeneity at the endothelial nitric oxide synthase (NOS3) locus influences heart failure outcomes. The prevalence of NOS3 variants differs in black and white cohorts, but the impact of these differences is unknown. METHODS AND RESULTS: Subjects (n = 352) in the Genetic Risk Assessment of Heart Failure (GRAHF) substudy of the African-American Heart Failure Trial were genotyped for NOS3...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Black or African American
Share to Black People

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diastole

Share to Drug Combinations

Share to Heart Failure

Share to Nitric Oxide Synthase Type III

Share to Stroke Volume

Share to Vasodilator Agents

Source

Identifiers

PMID: 19327620
DOI: 10.1016/j.cardfail.2008.10.028

Genes

NOS3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial.PMID 19327620Read ↗

G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFT.Semantic proximity Read ↗

Polymorphisms of endothelial nitric oxide synthase gene in systolic heart failure: an haplotype analysis.Semantic proximity Read ↗

Race, common genetic variation, and therapeutic response disparities in heart failure.Semantic proximity Read ↗

Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study.Semantic proximity Read ↗

Endothelial nitric oxide synthase: From biochemistry and gene structure to clinical implications of NOS3 polymorphisms.Semantic proximity Read ↗

Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants.Semantic proximity Read ↗

Emerging role of pharmacogenomics in heart failure.Semantic proximity Read ↗

Variants in genes involved in functional pathways associated with hypertension in African Americans.Semantic proximity Read ↗

Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial.Semantic proximity Read ↗

Clinically relevant endothelial nitric oxide synthase polymorphisms and their impact on drug response.Semantic proximity Read ↗

Review: Heart failure with preserved ejection fraction in African Americans.Semantic proximity Read ↗

Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.